Monoclonal antibody | |
---|---|
Type | Fab' fragment |
Source | Mouse |
Target | Fibrin II, beta chain |
Clinical data | |
Trade names | FibriScint |
Pregnancy category |
|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
KEGG | |
(what is this?) (verify) |
Indium (111In) biciromab ( INN, trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood. [1] It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism, [2] but was withdrawn during clinical trials. [3]
Monoclonal antibody | |
---|---|
Type | Fab' fragment |
Source | Mouse |
Target | Fibrin II, beta chain |
Clinical data | |
Trade names | FibriScint |
Pregnancy category |
|
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
KEGG | |
(what is this?) (verify) |
Indium (111In) biciromab ( INN, trade name FibriScint, developed by Centocor) was a drug targeting fibrin, a protein involved in the clotting of blood. [1] It was the Fab' fragment of a mouse monoclonal antibody labelled with the radioisotope indium-111 for the diagnosis of thromboembolism, [2] but was withdrawn during clinical trials. [3]